| Literature DB >> 22239881 |
Joe N Kornegay1, Martin K Childers, Daniel J Bogan, Janet R Bogan, Peter Nghiem, Jiahui Wang, Zheng Fan, James F Howard, Scott J Schatzberg, Jennifer L Dow, Robert W Grange, Martin A Styner, Eric P Hoffman, Kathryn R Wagner.
Abstract
Mutations in the dystrophin gene cause Duchenne and Becker muscular dystrophy in humans and syndromes in mice, dogs, and cats. Affected humans and dogs have progressive disease that leads primarily to muscle atrophy. Mdx mice progress through an initial phase of muscle hypertrophy followed by atrophy. Cats have persistent muscle hypertrophy. Hypertrophy in humans has been attributed to deposition of fat and connective tissue (pseudohypertrophy). Increased muscle mass (true hypertrophy) has been documented in animal models. Muscle hypertrophy can exaggerate postural instability and joint contractures. Deleterious consequences of muscle hypertrophy should be considered when developing treatments for muscular dystrophy.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22239881 PMCID: PMC5951392 DOI: 10.1016/j.pmr.2011.11.014
Source DB: PubMed Journal: Phys Med Rehabil Clin N Am ISSN: 1047-9651 Impact factor: 1.784